Are you looking for creative ways to reach and engage your healthcare audience?
Partner with medwireNews and see how our content and tactics can boost your independent educational activities to optimize your goals.
Specialists in medical education and content creation, we provide solutions that grab the attention of healthcare professionals and inform them on key messages in convenient, easily accessible and timely formats.
Our services can help you build trusted relationships with your healthcare professional audience by supporting them in the knowledge they need to stay up to date and ensure the continued learning essential to improving patient care.
- 17-03-2024|
Apitegromab shows motor function benefits in patients with SMA
Apitegromab improves motor function in patients with later-onset spinal muscular atrophy, show the results of the phase 2 TOPAZ study.
- 17-03-2024|
- |
- Article |
- Diabetes |
- Highlight |
- Paediatrics |
Home insulin pump use feasible for hospitalised children with type 1 diabetes
For children with type 1 diabetes who are admitted to hospital, continuing with a home insulin pump is feasible for the prevention of hyperglycemia and hypoglycemia, suggests research published in JAMA Network Open.
- 01-03-2024|
- |
- Article |
- Endocrinology |
- Highlight |
Autoimmune disease risk increased after surgical remission of Cushing’s disease
Patients with Cushing’s disease who achieve remission following surgery have an increased incidence of autoimmune disease, suggest findings published in the Annals of Internal Medicine in February 2024.
- 29-02-2024|
- |
- Article |
- Highlight |
- Rheumatology |
Mycophenolate mofetil withdrawal feasible in SLE patients with stable disease
Patients with systemic lupus erythematosus may be able to stop taking mycophenolate mofetil once their condition becomes stable without significantly increasing their risk for flare compared with continuing treatment, suggests an open-label, randomized controlled trial.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
- 22-02-2024|
Tixagevimab plus cilgavimab offers COVID-19 protection for haematological cancer patients
Tixagevimab and cilgavimab immunoprophylaxis may help protect patients with haematological malignancies from COVID-19 infection and hospitalisation, suggests a research letter published in JAMA Oncology.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
- 15-02-2024|
Blood immunoassay shows high diagnostic accuracy for Alzheimer’s disease pathology
A commercially available plasma phosphorylated (p)-tau217 immunoassay outperforms other biomarkers in accurately identifying biological Alzheimer’s disease, suggest findings from a study across three observational cohorts.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
- Rheumatology
- Conference Coverage & Reporting
- Oncology
- Conference Coverage & Reporting
- Neurology
- Conference Coverage & Reporting
- Neurology
- Conference Coverage & Reporting
- Diabetes
- Expert Interviews & Discussion
- Rheumatology
- Conference Coverage & Reporting